Skip to main content

Table 5 MDR features of S . Concord

From: A meta-analysis of the proportion of antimicrobial resistant human Salmonella isolates in Ethiopia

Author MDR profiles No. (%)
[13]a Amp Chl Cro Gen Sxt 41(48.8)
Amp Chl Cro Gen Sxt Tet 29(34.5)
Amp Chl Cro Gen Nal Sxt Tet 5(6.0)
[14]b Amp Azt Chl (Cep Cfp Cfr Cft Cfz Cpo Cro Ctz ) Str SulTmp 34(97.1)
  Amp Azt Chl (Cep Cfp Cfr Cft Cfz Cpo Ctz ) Str SulTmp 1(2.9)
[15]c Amp Chl Cro Gen Str Sul Sxt Tmp 3(11.5)
Amp Chl Cro Gen Sul Str Sxt Tet Tmp 19(73.1)
Amp Chl Cro Gen Nal Str Sul Sxt Tet Tmp 4(15.4)
[41]d Amp Chl Cfo Cro Gen Str Sul Tet Tmp 8 (100)
  1. Amp = ampicillin; Azt = aztreonam; Cep = cephalothin; Cfo = cefotaxime; Cfp = cefepime; Cfr = cefuroxime; Cft = ceftiofur; Cfz = cefazolin; Cpo = cefpodoxime; Cro = ceftriaxone; Ctz = ceftazidime; Chl = chloramphenicol; Gen = gentamicin; Nal = nalidixic acid; Sul = sulfamethoxazole; Str = streptomycin; Sxt = co-trimoxazole; Tet = tetracycline; Tmp = trimethoprim.
  2. aEach profile was recorded in more than 5% of the MDR isolates. One isolate was resistant to ofloxacin.
  3. bResistance to gentamicin (97%), tetracycline (69%) and intermediate resistance to ciprofloxacin (14%) were recorded.
  4. cSeven isolates showed intermediate resistance to ciprofloxacin.
  5. dResistance to florfenicol (6/8), colistin (1/8) and intermediate resistance to ciprofloxacin (6/8) were recorded.